Esther Hulleman

Amsterdam UMC, Cancer Center Amsterdam

Affiliated withCancer Center Amsterdam Princess Máxima Center for Pediatric Oncology

Research Area

Biography

Esther Hulleman has not added Biography.
If you are Esther Hulleman and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 7	2020

Other Publications

Article	Year
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget\| PubMed ID: 21321380	2010
Blood platelets contain tumor-derived RNA biomarkers. Blood\| PubMed ID: 21832279	2011
PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation. Oncotarget\| PubMed ID: 22184287	2011
EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 22696229	2012
EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion. Neuro-oncology\| PubMed ID: 22723427	2012
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma. Oncotarget\| PubMed ID: 24495907	2014
Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis. Scientific reports\| PubMed ID: 24919120	2014
A dual program for translation regulation in cellular proliferation and differentiation. Cell\| PubMed ID: 25215487	2014
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nature medicine\| PubMed ID: 25939062	2015
A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer. Oncotarget\| PubMed ID: 26967057	2016
Multiregional tumor drug-uptake imaging by PET and microvascular morphology in end-stage diffuse intrinsic pontine glioma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine\| PubMed ID: 28818988	2017
Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies. Experimental cell research\| PubMed ID: 28947132	2017
Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma. Oncotarget\| PubMed ID: 28947983	2017
Signaling pathways and mesenchymal transition in pediatric high-grade glioma. Cellular and molecular life sciences : CMLS\| PubMed ID: 29164272	2018
Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human Medulloblastoma. Cell reports\| PubMed ID: 29562177	2018
IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma. PloS one\| PubMed ID: 29621254	2018
MELK Inhibition in Diffuse Intrinsic Pontine Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 30061363	2018
An efficient method for the transduction of primary pediatric glioma neurospheres. MethodsX\| PubMed ID: 30622915	2018
Preclinical therapeutic targets in diffuse midline glioma. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy\| PubMed ID: 31202081	2019
MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors. Neuro-oncology\| PubMed ID: 31504799	2020
Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin. EBioMedicine\| PubMed ID: 31735550	2019
Patient-Derived Orthotopic Xenograft Models of Pediatric Brain Tumors: In a Mature Phase or Still in Its Infancy? Frontiers in oncology\| PubMed ID: 31970083	2019
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 32165429	2020
Development of transient radioresistance during fractionated irradiation in vitro. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology\| PubMed ID: 32344261	2020